The transition to Vault CRM serves as the foundation for Amgen’s agentic commercial strategy. Scott Skellenger, senior vice president and chief information officer at Amgen, stated that the platform will provide the necessary speed and agility to support the company’s global therapy launches. The software suite includes the Agentic Call Report, a tool designed to generate commercial evidence and identify treatment barriers that were previously difficult to track.
In section Releases
Amgen Selects Veeva Vault CRM for Global Operations
Amgen is moving its worldwide commercial operations to the Veeva Vault CRM platform, marking a decade-long expansion of the partnership between the two companies. The move aims to integrate agentic technology into the pharmaceutical giant’s workflow to accelerate the delivery of new therapies to patients struggling with complex diseases.
Matt Farrell, president of commercial strategy at Veeva, emphasized that the technology will reshape how Amgen engages with healthcare professionals. By automating data collection and analysis, the company intends to refine its approach to market launches. Veeva, currently serving over 1,500 customers as a Public Benefit Corporation, continues to focus its cloud infrastructure specifically on the requirements of the life sciences industry.
Comments (0)
No comments yet. Be the first!